International Journal of Radiation Oncology * Biology * Physics
Volume 44, Issue 2 , Pages 323-326 , May 1999

Follow-up costs after external radiation for low risk prostate cancer

  • Kevin Tralins, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Washington, Seattle, WA, USA
    • Puget Sound Health Care System, Department of Veterans Affairs, Seattle, WA, USA
    • ,
  • Kent Wallner, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Washington, Seattle, WA, USA
    • Puget Sound Health Care System, Department of Veterans Affairs, Seattle, WA, USA
    • Corresponding Author InformationReprint requests to: Kent Wallner, Radiation Oncology, Puget Sound Health Care System, Department of Veterans Affairs, 1660 S. Columbian Way (174), Seattle, WA 98108-1597

,Accepted 30 December 1998.

References 

  1. Browman GP, Newman TE, Mohide EA, et al.  Progress of clinical oncology guidelines development using the practice guidelines development cycle (The role of practitioner feedback). J Clin Oncol. 1998;16:1226–1231
  2. Hanks GE, Dunlap K. A comparison of the cost of various treatment methods for early cancer of the prostate. Int J Radiat Oncol Biol Phys. 1986;12:1879–1881
  3. ASTRO . Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys. 1997;37:1035–1041
  4. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481
  5. Zietman AL, Coen JJ, Shipley WU, et al.  Radical radiation therapy in the management of prostatic adenocarcinoma (The initial prostate specific antigen value as a predictor of treatment outcome). J Urol. 1994;151:640–645
  6. Zagars GK, Pollack A, Kavadi VS. Prostate-specific antigen and radiation therapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 1995;32:293–306
  7. Rogers E, Ohori M, Kassabian VS, et al.  Salvage radical prostatectomy (Outcome measured by serum prostate specific antigen levels). J Urol. 1995;153:104–110
  8. Medical Research Council Prostate Cancer Working Party Investigators Group . Immediate versus deferred treatment for advanced prostatic cancer (Initial results of the Medical Research Council trial). Br J Urol. 1997;79:235–246
  9. Rosselli-Del-Turco M, Palli D, Cariddi A, et al.  Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. JAMA. 1994;271:1593–1597
  10. Morris S, Corder A, Taylor I. What are the benefits of routine cancer follow-up?. Postgrad Med J. 1992;68:904–907
  11. Zelefsky MJ, Leibel SA, Gaudin PB, et al.  Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys. 1998;41:491–500
  12. Hanks GE, Hanlon AL, Schultheiss TE, et al.  Dose escalation with 3D conformal treatment (Five year outcomes, treatment optimization, and future directions). Int J Radiat Oncol Biol Phys. 1998;41:501–510
  13. Fukunaga-Johnson N, Sandler HM, McLaughlin PW, et al.  Results of 3D conformal radiotherapy in the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys. 1997;38:311–317

PII: S0360-3016(99)00017-6

International Journal of Radiation Oncology * Biology * Physics
Volume 44, Issue 2 , Pages 323-326 , May 1999

Article Tools

* Image Usage & Resolution